Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

Figure 2

Trend over time of measures of clinical subjective and objective variables. Trend over time of measures of clinical subjective and objective variables along the two treatment arms. Subjective: (A) visual analogue scale (VAS) score for pain. Objective: (B) swollen joint count over 28 joints (Sw28), (C) tender joint count over 28 joints (Ten28), (D) serum levels of the erythrocyte sedimentation rate (ESR), (E) serum levels of C-reactive protein (CRP), and (F) absolute mean values of disease activity score among 28 joints (DAS28). *P < 0.05 related to differences between treatment arms.

Back to article page